Aimei Health Technology Co., Ltd cash flow to debt ratio of -27.92% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Aimei Health Technology Co., Ltd's free cash flow has increased 15.94% from $-672.29K last year to $-565.10K, signaling increasing performance

Aimei Health Technology Co., Ltd's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Aimei Health Technology Co., Ltd's debt has decreased relative to shareholder equity from 0.00 last year to 0.00 today, signaling strengthened financials

Aimei Health Technology Co., Ltd has negative EBITDA, making leverage ratio unreliable

Aimei Health Technology Co., Ltd earns at least as much interest as it pays. Interest obligations are fully covered.

Aimei Health Technology Co., Ltd has insufficient data to evaluate this check.

Aimei Health Technology Co., Ltd's short-term liabilities of $3.37M exceed its short-term assets of $2.93K, signaling financial risk

Aimei Health Technology Co., Ltd's return on assets of 3.29% is lower than the 5.00% threshold, indicating inefficient asset utilization

Aimei Health Technology Co., Ltd's return on equity of 2.49%, is lower than 15.00%, indicating bad performance

Aimei Health Technology Co., Ltd's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Aimei Health Technology Co., Ltd has insufficient public price history to evaluate earnings stability.

Aimei Health Technology Co., Ltd has negative free cash flow, indicating the company is burning cash rather than generating it

Aimei Health Technology Co., Ltd has negative free cash flow, indicating cash burn

Aimei Health Technology Co., Ltd's yearly earnings has decreased 58.47% since last year from $2.55M to $1.06M, signaling decreasing performance

Aimei Health Technology Co., Ltd's yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -5.83% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Aimei Health Technology Co., Ltd has insufficient revenue history to calculate 3-year revenue CAGR.

Aimei Health Technology Co., Ltd has insufficient public price history to evaluate revenue consistency.

Aimei Health Technology Co., Ltd has insufficient public price history to evaluate ROE consistency.

Aimei Health Technology Co., Ltd has insufficient data to evaluate this check.

Aimei Health Technology Co., Ltd has an earnings yield of 3.25%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Aimei Health Technology Co., Ltd is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Aimei Health Technology Co., Ltd has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Aimei Health Technology Co., Ltd has insufficient data to evaluate this check.

Aimei Health Technology Co., Ltd has insufficient diluted EPS history to calculate the PEG ratio.

Aimei Health Technology Co., Ltd has a price-to-book ratio of 1.59x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Aimei Health Technology Co., Ltd has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue